ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER
Clinical trials for ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy shows promise for Tough-to-Treat lung cancer
Disease control OngoingThis study tests a new combination of two drugs (ceralasertib and durvalumab) against standard chemotherapy (docetaxel) in people with advanced non-small cell lung cancer that has worsened after previous treatments. About 594 participants will be randomly assigned to one of the t…
Matched conditions: ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 17, 2026 03:14 UTC
-
Lung cancer treatment gets a shot in the arm: new Under-the-Skin drug aims to simplify care
Disease control OngoingThis study tests a new way to give the drug amivantamab as a quick shot under the skin, instead of a long IV drip, for people with a certain type of advanced lung cancer. About 418 participants whose cancer has worsened after standard treatments will receive either the new shot o…
Matched conditions: ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated May 05, 2026 11:54 UTC